Atlas Venture Fund XI, L.P. 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | Xilio Therapeutics, Inc. XLO | Atlas Venture Fund XI, L.P. | 0 0.000% | -2,023,402 (Position Closed) | Filing |
| 2021-11-05 4:43 pm Purchase | 2021-10-26 | 13G | Xilio Therapeutics, Inc. XLO | Atlas Venture Fund XI, L.P. | 2,023,402 7.600% | 2,023,402 (New Position) | Filing |